Supply Chain State of the Union: Understanding the Current Manufacturing Environment for Radiopharmaceuticals
• Discussing the need for in-house manufacturing and the current and future roles of CDMOs in the radiopharma supply chain
• Exploring funding trends for companies developing radiopharmaceuticals and CDMOs supporting this sector
• Outlining current isotope availability, identifying supply bottlenecks, and projecting future isotype availability